Timothy M Mayleben Marinus Pharmaceuticals, Inc. (MRNS) insider trading activity

Timothy M Mayleben is Director of MARINUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of MRNS, which is worth approximately $0. The most recent transaction as insider was on Feb 11, 2025, when has been sold 2,300 shares (Common Stock) at a price of $0.55 per share, resulting in proceeds of $1,265. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

TIMOTHY M MAYLEBEN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 11 2025	SELL Sale (or disposition) back to the issuer	$1,265 $0.55 p/Share	2,300 Reduced 100.0%	0 Common Stock
Feb 07 2025	SELL Sale (or disposition) back to the issuer	$2,530 $0.55 p/Share	4,600 Reduced 66.67%	2,300 Common Stock
Jun 18 2024	BUY Grant, award, or other acquisition	-	2,300 Added 8.62%	24,375 Common Stock
Jan 18 2024	BUY Grant, award, or other acquisition	-	4,600 Added 17.24%	22,075 Common Stock
Jan 26 2023	BUY Grant, award, or other acquisition	-	3,600 Added 17.08%	17,475 Common Stock
Feb 04 2022	BUY Grant, award, or other acquisition	-	2,750 Added 16.54%	13,875 Common Stock

Also insider at

ESPR

Esperion Therapeutics, Inc. Healthcare

President & CEO

LABP

Landos Biopharma, Inc. Healthcare

TMM